Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Some people may temporarily lose more hair in certain areas after a hair transplant.

The Nd:YAG laser is a successful and safe way to treat ingrown and pincer nails.

A woman developed thick gums from everolimus treatment after a kidney transplant.

Itch is a common symptom in patients with chronic venous insufficiency, often accompanied by burning and pain.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Itch is a common symptom in patients with chronic venous insufficiency, often worsening with standing or sitting and occurring mostly in the evening or at night.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Liver transplantation is a viable option for children with propionic acidemia, improving quality of life and diet, but does not remove all risks and long-term brain outcomes are uncertain.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Targeting the skin's endocannabinoid system could help treat skin disorders.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Nanocapsules can improve clobetasol delivery to hair follicles, reducing side effects.